Management of pleural infections

References

• Light RW. Parapneumonic effusions and empyema. In: Light RW, editor. Pleural diseases. Philadelphia, PA: Lippincott Williams & Wilkins; 2007. p. 179–210.
   Google Scholar
• Ferreiro L, San José ME, Valdés L. Management of parapneumonic pleural effusion in adults. Arch Bronconeumol. 2015;51:637–646.
   PubMed Web of Science ®Google Scholar
• Dean NC, Griffith PP, Sorensen JS, et al. Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia. Chest. 2016;149:1509–1515.
   PubMed Web of Science ®Google Scholar
• Davies HE, Davies RJO, Davies CWH. On behalf of the BTS pleural disease guideline group. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41–ii53.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Davies CWH, Nunn AJ, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005 Erratum, N Engl J Med 2005;352:2146;352:865–874.
   PubMed Web of Science ®Google Scholar
• Voiriot G, Dury S, Parrot A, et al. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest. 2011;139:387–394.
   PubMed Web of Science ®Google Scholar
• Finley C, Clifton J, Fitzgerald JM, et al. Empyema: an increasing concern in Canada. Can Respir J. 2008;15:85–89.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Zhu Y, Nuorti JP, et al. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66:663–668.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518–526.
   PubMed Web of Science ®Google Scholar
• Desai G, Amadi W. Three years’ experience of empyema thoracis in association with HIV infection. Trop Doct. 2001;31:106–107.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Hallifax R, Rahman NM. New therapeutic approaches to pleural infection. Curr Opin Infect Dis. 2013;26:196–202.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64:592–597.
   PubMed Web of Science ®Google Scholar
• Reissig A, Copetti R, Mathis G, et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012;142:965–972.
   PubMed Web of Science ®Google Scholar
• Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151:1700–1708.
   PubMed Web of Science ®Google Scholar
• Givan DC, Eigen H. Common pleural effusions in children. Clin Chest Med. 1998;19:363–371.
   PubMed Web of Science ®Google Scholar
• Li STT, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26–33.
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Selva L, Pallares R. Influence of pneumococcal vaccine on the incidence of empyema. Curr Opin Pulm Med. 2010;16:394–398.
   PubMed Web of Science ®Google Scholar
• Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. Qjm. 1996;89:285–289.
   PubMed Web of Science ®Google Scholar
• Meyer CN, Rosenlund S, Nielsen J, et al. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis. 2011;43:165–169.
   PubMed Web of Science ®Google Scholar
• Nasreen N, Mohammed KA, Hardwick J, et al. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis. 2001;183:1638–1645.
   PubMed Web of Science ®Google Scholar
• Wilkosz S, Edwards LA, Bielsa S, et al. Characterization of a new mouse model of empyema and the mechanisms of pleural invasión by Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2012;46:180–187.
   PubMed Web of Science ®Google Scholar
• Sahn SA, Reller LB, Taryle DA, et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis. 1983;128:811–815.
   PubMed Web of Science ®Google Scholar
• Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med. 2008;14:310–315.
   PubMed Web of Science ®Google Scholar
• Idell S, Mazar A, Cines D, et al. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med. 2002;166:920–926.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Maskell NA. Treatment of complicated pleural effusions in 2013. Clin Chest Med. 2013;34:47–62.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality signifi cance. Am J Respir Crit Care Med. 2006;174:817–823.
   PubMedGoogle Scholar
• Whiley RA, Beighton D, Winstanley TG, et al. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol. 1992;30:243–244.
   PubMed Web of Science ®Google Scholar
• Lin YT, Chen TL, Siu LK, et al. Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic eff usion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis. 2010;29:1003–1010.
   PubMed Web of Science ®Google Scholar
• Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema. Emphasis on klebsiella pneumonia in patients with diabetes mellitus. Chest. 2000;117:1685–1689.
   PubMed Web of Science ®Google Scholar
• Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS One. 2012;7:e30074.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Esquerda A, Vives M, et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50:161–165.
   PubMed Web of Science ®Google Scholar
• Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identifi cation and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30:289–294.
   PubMed Web of Science ®Google Scholar
• Tu CY, Chen CH. Spontaneous bacterial empyema. Curr Opin Pulm Med. 2012;18:355–358.
   PubMed Web of Science ®Google Scholar
• Hendrickson DJ, Blumberg DA, Joad JP, et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030–1032.
   PubMed Web of Science ®Google Scholar
• Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis. 2011;53:254–261.
   PubMed Web of Science ®Google Scholar
• Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol. 2010;48:520–525.
   PubMed Web of Science ®Google Scholar
• Thomas MF, Sheppard C, Guiver M, et al. Paediatric pneumococcal empyema serotypes have not changed following introduction of the 13 valent pneumococcal vaccine. Thorax. 2013;68:A39.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Wrightson JM, Belcher E, et al. Pleural infection: past, present, and future directions. Lancet Respir Med. 2015;3:563–577.
   PubMed Web of Science ®Google Scholar
• Ko SC, Chen KY, Hsueh PR, et al. Fungal empyema thoracis: an emerging clinical entity. Chest. 2000;117:1672–1678.
   PubMed Web of Science ®Google Scholar
• Lewis KL, Doherty DE, Ribes J, et al. Empyema caused by trichomonas. Chest. 2003;123:291–292.
   PubMed Web of Science ®Google Scholar
• Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med. 1980;69:507–512.
   PubMed Web of Science ®Google Scholar
• Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55.
   PubMed Web of Science ®Google Scholar
• Mj F, Te A, Dm Y, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250.
   PubMed Web of Science ®Google Scholar
• Faguera M, Carratalá J, Bielsa S, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38:1173–1179.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145:848–855.
   PubMed Web of Science ®Google Scholar
• Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest. 2010;137:467–479.
   PubMed Web of Science ®Google Scholar
• Kraus GJ. The split pleura sign. Radiology. 2007;243:297–298.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Pardina M, Alemán C, et al. Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics. Respirology. 2017;22:1199–1204.
   PubMed Web of Science ®Google Scholar
• Svigals PZ, Chopra A, Ravenel JG, et al. The accuracy of pleural ultrasonography in diagnosisng complicated parapneumonic pleural effusions. Thorax. 2017;72:94–95.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Rahman NM. Effusions from infections: parapneumonic pleural effusion and empyema. In: Light RW, Gary Lee YC, eds. Texbook of pleural diseases. 3rd ed. London: CRC Press; 2016. p. 295–330.
   Google Scholar
• Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66:658–662.
   PubMed Web of Science ®Google Scholar
• Heffner JE, Klein JS, Hampson C. Interventional management of pleural infections. Chest. 2009;136:1148–1159.
   PubMed Web of Science ®Google Scholar
• Skouras V, Awdankiewicz A, Light RW. What size parapneumonic effusions should be sampled? Thorax. 2010;65:91.
   PubMed Web of Science ®Google Scholar
• Cobas-Paz A, Botana-Rial M, Fernández-Villar A. ¿Existe una pleuritis paraneumónica decapitada. Arch Bronconeumol. 2010;46:282–283.
   PubMedGoogle Scholar
• Ferreiro L, Pereiro T, San José E, et al. Behavior of nucleated cells in various types of pleural effusion. Rev Clin Esp. 2017;217:136–143.
   PubMed Web of Science ®Google Scholar
• Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions. An evidence-based guideline. Chest. 2000;118:1158–1171.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Mishra EK, Davies HE, et al. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med. 2008;178:483–490.
   PubMed Web of Science ®Google Scholar
• Pine JR, Hollman JL. Elevated pleural fluid pH in Proteus mirabilis empyema. Chest. 1983;84:109–111.
   PubMed Web of Science ®Google Scholar
• Ng L, Dabscheck E, Hew M. Diagnosis of complicated parapneumonic effusion by pleural pH measurement is jeopardized by inadequate physician knowledge and guideline-discordant laboratory practice. Respir Med. 2017;122:30–32.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Valencia H, Bielsa S. Factors influencing pleural drainage in parapneumonic effusions. Rev Clin Esp. 2016;216:361–366.
   PubMed Web of Science ®Google Scholar
• Jiménez-Castro D, Díaz-Nuevo G, Sueiro A, et al. Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration. 2005;72:357–364.
   PubMed Web of Science ®Google Scholar
• Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and longterm survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160:1682–1687.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Vives M, Esquerda A, et al. Usefulness of the british thoracic society and the American college of chest physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med. 2006;100:933–937.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Bielsa S, Esquerda A, et al. Pleural fluid creactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med. 2012;23:447–450.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Bielsa S, Esquerda A, et al. Pleural fluid Creactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med. 2012;23:447–450.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Vives M, Cao G, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 2009;34:1383–1389.
   PubMed Web of Science ®Google Scholar
• San José ME, Valdés L, Vizcaíno LH, et al. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med. 2010;58:971–976.
   PubMed Web of Science ®Google Scholar
• Ming-Xiang Z, Rong-Rong Z, Wen-Ju W, et al. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: A systemic review and meta-analysis. Am J Emerg Med. 2012;30:1907–1914.
   PubMed Web of Science ®Google Scholar
• Dixon G, Lama-Lopez A, Bintcliffe OJ, et al. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection. Respir Res. 2017;18:30.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Galindo C, Esquerda A, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated nonpurulent from uncomplicated parapenumonic effusions. Respirology. 2008;13:58–62.
   PubMed Web of Science ®Google Scholar
• Skouras V, Boultadakis E, Nikoulis D, et al. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology. 2012;17:308–314.
   PubMed Web of Science ®Google Scholar
• Bielsa S, Valencia H, Ruiz-González A, et al. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions. Lung. 2014;192:577–581.
   PubMed Web of Science ®Google Scholar
• Lin MC, Chen YC, Wu JT, et al. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest. 2009;136:205–211.
   PubMed Web of Science ®Google Scholar
• McCann FJ, Chapman SJ, Yu WC, et al. Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings. Plos One. 2012;7:e49894.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Vives M, Esquerda A. Tumor necrosis factor-alpha in pleural fluid. A marker of complicated parapneumonic effusions. Chest. 2004;125:160–164.
   PubMed Web of Science ®Google Scholar
• Soderblom T, Nyberg P, Teppo AM, et al. Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996;9:1652–1655.
   PubMed Web of Science ®Google Scholar
• San José ME, Valdés L, González-Barcala FJ, et al. Diagnostic value of proinflammatory interleukins in parapneumonic effusions. Am J Clin Pathol. 2010;133:884–891.
   PubMed Web of Science ®Google Scholar
• Daniil ZD, Zintzaras E, Kiropoulos T, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J. 2007;30:957–964.
   PubMed Web of Science ®Google Scholar
• Agrenius V, Gustafsson LE, Widstrom O. Tumour necrosis factor-a and nitric oxide, determined as nitrite, in malignant pleural effusion. Respir Med. 1994;88:743–748.
   PubMed Web of Science ®Google Scholar
• San José ME, Ferreiro L, Soneira ME, et al. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions. Am J Clin Pathol. 2014;142:467–473.
   PubMed Web of Science ®Google Scholar
• Vives M, Porcel JM, Gázquez I, et al. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions. Respiration. 2000;67:433–438.
   PubMed Web of Science ®Google Scholar
• Alemán C, Alegre J, Segura RM, et al. Polymorphonuclear elastase in the early diagnosis of complicated pyogenic pleural effusions. Respiration. 2003;70:462–467.
   PubMed Web of Science ®Google Scholar
• Alegre J, Jufresa J, Segura R, et al. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic effusions. Eur Respir J. 2002;19:320–325.
   PubMed Web of Science ®Google Scholar
• Oikonomidi S, Kostikas K, Kalomenidis I, et al. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration. 2010;80:285–291.
   PubMed Web of Science ®Google Scholar
• Tsilioni I, Kostikas K, Kalomenidis I, et al. Diagnostic accuracy of biomarkers of oxidative stress in parapneumonic pleural effusions. Eur J Clin Invest. 2011;41:349–356.
   PubMed Web of Science ®Google Scholar
• Ozsu S, Abul Y, Mentese A, et al. Pentraxin-3: a novel biomarker for discriminating parapneumonic from other exudative effusions. Respirology. 2013;18:657–662.
   PubMed Web of Science ®Google Scholar
• Chung CL, Hsiao SH, Hsiao G, et al. Clinical importance of angiogenic cytokines, fibrinollytic activity and effusion size in parapneumonic effusions. PloS One. 2013;8:e53169.
   PubMed Web of Science ®Google Scholar
• Tobin CL, Gary Lee YC. Pleural infection: what we need to know but don’t. Curr Opin Pulm Med. 2012;18:321–325.
   PubMed Web of Science ®Google Scholar
• Villena-Garrido V, Cases-Viedma E, Fernández-Villar A, et al. Normativa sobre el diagnóstico y tratamiento del derrame pleural. Actualización. Arch Bronconeumol. 2014;50:235–249.
   PubMedGoogle Scholar
• Teixeira LR, Sasse SA, Villarino MA, et al. Antibiotic levels in empyemic pleural fluid. Chest. 2000;117:1734–1739.
   PubMed Web of Science ®Google Scholar
• Taryle DA, Good JT, Morgan EJ, et al. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother. 1981;7:171–177.
   PubMed Web of Science ®Google Scholar
• Kroboth FJ, Yu VL, Reddy SC, et al. Clinicoradiographic correlation with the extent of Legionnaire disease. AJR Am J Roentgenol. 1983;141:263–268.
   PubMed Web of Science ®Google Scholar
• Thys JP, Vanderhoeft P, Herchuelz A, et al. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest. 1988;93:530–532.
   PubMed Web of Science ®Google Scholar
• Shohet I, Yellin A, Meyerovitch J, et al. Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model. Antimicrob Agents Chemother. 1987;31:982–985.
   PubMed Web of Science ®Google Scholar
• Liapakis IE, Kottakis I, Tzatzarakis MN, et al. Penetration of newer quinolones in the empyema fluid. Eur Respir J. 2004;24:466–470.
   PubMed Web of Science ®Google Scholar
• Liapakis IE, Light RW, Pitiakoudis MS, et al. Penetration of clarithromicin in experimental pleural empyema model fluid. Respiration. 2005;72:296–300.
   PubMed Web of Science ®Google Scholar
• Shen KR, Bribriesco A, Crabtree T, et al. The American association for thoracic surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153:e129–e146.
   PubMed Web of Science ®Google Scholar
• Redden MD, Chin TY, van Driel ML. Surgical versus non-surgical management for pleural empyema. Cochrane Database Syst Rev. 2017;3:CD010651.
   PubMedGoogle Scholar
• Storm HK, Krasnik M, Bang K, et al. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax. 1992;47:821–824.
   PubMed Web of Science ®Google Scholar
• Simmers TA, Jie C, Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg. 1999;47:77–81.
   PubMed Web of Science ®Google Scholar
• Letheulle J, Tattevin P, Saunders L, et al. Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion. PLoS One. 2014;9:e84788.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010;137:536–543.
   PubMed Web of Science ®Google Scholar
• Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291–295.
   PubMed Web of Science ®Google Scholar
• Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37–42.
   PubMed Web of Science ®Google Scholar
• Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Care Med. 2004;170:49–53.
   PubMed Web of Science ®Google Scholar
• Lee YC. Ongoing search for effective intrapleural therapy for empyema. Is streptokinase the answer? Am J Respir Crit Care Med. 2004;170:1–2.
   PubMed Web of Science ®Google Scholar
• Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117:1728–1733.
   PubMed Web of Science ®Google Scholar
• Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest. 2012;142:401–411.
   PubMed Web of Science ®Google Scholar
• Nie W, Liu Y, Ye J, et al. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J. 2014;8:281–291.
   PubMed Web of Science ®Google Scholar
• Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416–421.
   PubMed Web of Science ®Google Scholar
• Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658–660.
   PubMed Web of Science ®Google Scholar
• Diacon AH, Koegelenberg CF, Bolliger CT. A trial of intrapleural streptokinase. N Engl J Med. 2005;352:2243–2245. author reply: 2243–5.
   PubMedGoogle Scholar
• Misthos P, Sepsas E, Konstantinou M, et al. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A Prospective Study. Eur J Cardiothorac Surg. 2005;28:599–603.
   PubMed Web of Science ®Google Scholar
• Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002;57:343–347.
   PubMed Web of Science ®Google Scholar
• Singh M, Mathew JL, Chandra S, et al. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr. 2004;93:1443–1445.
   PubMed Web of Science ®Google Scholar
• Thommi G, Shehan JC, Robison KL, et al. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med. 2012;106:716–723.
   PubMed Web of Science ®Google Scholar
• Froudarakis ME, Kouliatsis G, Steiropoulos P, et al. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med. 2008;102:1694–1700.
   PubMed Web of Science ®Google Scholar
• Alemán C, Porcel JM, Alegre J, et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: A prospective randomized study. Lung. 2015;193:993–1000.
   PubMed Web of Science ®Google Scholar
• Piccolo F, Pitman N, Bhatnagar R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An Effective and Safe Alternative to Surgery. Ann Am Thorac Soc 2014;11:1419–1425.
   PubMedGoogle Scholar
• Mehta HJ, Biswas A, Penley AM, et al. Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease. Respiration. 2016;91:101–106.
   PubMed Web of Science ®Google Scholar
• McClune JR, Wilshire CL, Gorden JA, et al. Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections. Can Respir J. 2016;2016:9796768.
   PubMedGoogle Scholar
• Majid A, Kheir F, Folch A, et al. Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A Single-Center Experience. Ann Am Thorac Soc. 2016;13:1512–1518.
   PubMed Web of Science ®Google Scholar
• Majid A, Ochoa S, Chatterji S, et al. Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology. Ann Am Thorac Soc. 2017;14:342–346.
   PubMed Web of Science ®Google Scholar
• Bishwakarma R, Shah S, Frank L, et al. Mixing it up: coadministration of tPA/DNase in complicated parapneumonic pleural effusions and empyema. J Bronchology Interv Pulmonol. 2017;24:40–47.
   PubMed Web of Science ®Google Scholar
• Popowicz N, Bintcliffe O, De Fonseka D, et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc. 2017;14:929–936.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Rahman NM, Colice GL, et al. Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes/No. Chest. 2014;145:14–23.
   PubMed Web of Science ®Google Scholar
• Hooper CE, Edey AJ, Wallis A, et al. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J. 2015;46:456–463.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Valencia H, Bielsa S. Manual intrapleural saline flushing plus urokinase: A potentially useful therapy for complicated parapneumonic effusions and empyemas. Lung. 2017;195:135–138.
   PubMed Web of Science ®Google Scholar
• Wrightson JM, Maskell NA. Pleural infection. Clin Med. 2012;12:82–86.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Takeo S, Suemitsu R, et al. Video-assisted thoracic surgery for fibropurulent thoracic empyema: a bridge to open thoracic surgery. Ann Thorac Cardiovasc Surg. 2009;15:368–372.
   PubMed Web of Science ®Google Scholar
• Luh SP, Chou MC, Wang LS, et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest. 2005;127:1427–1432.
   PubMed Web of Science ®Google Scholar
• Chambers A, Routledge T, Dunning J, et al. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema? Interact Cardiovasc Thorac Surg. 2010;11:171–177.
   PubMed Web of Science ®Google Scholar
• Tacconi F, Pompeo E, Fabbi E, et al. Awake video-assisted pleural decortication for empyema thoracis. Eur J Cardiothorac Surg. 2010;37:594–601.
   PubMed Web of Science ®Google Scholar
• Schweigert M, Solymosi N, Dubecz A, et al. Surgical management of pleural empyema in the very elderly. Ann R Coll Surg Engl. 2012;94:331–335.
   PubMed Web of Science ®Google Scholar
• Kho P, Karunanantham J, Leung M, et al. Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact Cardiovasc Thorac Surg. 2011;12:724727.
   Web of Science ®Google Scholar
• Wait MA, Sharma S, Hohn J, et al. A randomized trial of empyema therapy. Chest. 1997;111:1548–1551.
   PubMed Web of Science ®Google Scholar
• Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg. 2006;76:120–122.
   PubMed Web of Science ®Google Scholar
• Bouros D, Antoniou KM, Chalkiadakis G, et al. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc. 2002;16:151–154.
   PubMed Web of Science ®Google Scholar
• Davies HE, Rosenstengel A, Lee YC. The diminishing role of surgery in pleural disease. Curr Opin Pulm Med. 2011;17:247–254.
   PubMed Web of Science ®Google Scholar
• Nwiloh J, Freeman H, Malnutrition: MC. An important determinant of fatal outcome in surgically treated pulmonary suppurative disease. J Natl Med Assoc. 1989;81:525–529.
   PubMed Web of Science ®Google Scholar
• Psallidas I, Kanellakis NI, Bhatnagar R, et al. A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the AUDIO study). Chest. 2018. doi:10.1016/j.chest.2018.02.031.
   Google Scholar
• Ky C, Ys L, Hc W, et al. Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med. 2000;19::837–843.
   PubMed Web of Science ®Google Scholar
• Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest. 1989;95:945–947.
   PubMed Web of Science ®Google Scholar